Skip to content

Emotional Brain Networks & Cognitive Functioning in Depression and Anxiety

Emotional Brain Networks & Cognitive Functioning in Depression and Anxiety

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03084042
Enrollment
105
Registered
2017-03-20
Start date
2016-07-31
Completion date
2019-06-30
Last updated
2018-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General Anxiety Disorder, Major Depressive Disorder

Keywords

emotional impairments, cognitive impairments

Brief summary

This study aims to 1) examine common and specific emotional and cognitive dysfunctions between Major Depression and generalized anxiety disorder; 2) Examine emotional and cognitive dysfunctions between the two disorders and healthy controls; 3) Examine the biomarkers predicting successful therapy or not.

Interventions

DEVICEfMRI

Sponsors

Sichuan Provincial People's Hospital
CollaboratorOTHER
The Fourth People's Hospital of Chengdu
CollaboratorOTHER
University of Electronic Science and Technology of China
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* GAD: 1. Diagnosis of Generalized Anxiety Disorder (GAD) according to DSM V criteria in a structured clinical interview for DSM-V Axis I disorders (SCID I; APA, 2014) and a confirmatory clinical interview 2. Duration of the current episode \> 3 weeks * MDD: 1. Diagnosis of current major depressive disorder in a structured clinical interview for DSM-V Axis I disorders (SCID I; APA, 2014) and a confirmatory clinical interview 2. Duration of the current episode \> 4 weeks

Exclusion criteria

* GAD: diagnosis of any other psychiatric Axis I disorder (except GAD) as a principal diagnosis within the past six months * MDD: diagnosis of any other psychiatric Axis I disorder (except MDD) as a principal diagnosis within the past six months

Design outcomes

Primary

MeasureTime frameDescription
Brain activity in the emotional and cognitive core regions of the brain as assessed by fMRI1 hour (assessed at study inclusion)fMRI based indices during emotional face processing

Secondary

MeasureTime frameDescription
Behavioral performance during the fMRI: empathy reactivity1 hour (assessed at study inclusion)Empathy in response to empathy inducing pictures (rated on Likert scale)
Behavioral performance during the fMRI: working memory1 hour (assessed at study inclusion)Working memory performance during fMRI
Behavioral performance during the fMRI: face processing1 hour (assessed at study inclusion)Accuracy during face processing
Symptom improvement after 3 months: depression3 monthsSymptoms of depression will be assessed using validated clinical scales (e.g. BDI)
Symptom improvement after 3 months: anxiety3 monthsSymptoms of generalized anxiety will be assessed using validated clinical scales (e.g. Penn State Worry Questionnaire)
Cognitive performance at study inclusion1 hour (assessed at study inclusion)Executive functions as assessed via computerized tests (CANTAB)

Countries

China

Contacts

Primary ContactBenjamin Becker, Dr.
ben_becker@gmx.de

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026